Targeting Rho in cardiovascular disease

Circ Res. 2000 Sep 29;87(7):526-8. doi: 10.1161/01.res.87.7.526.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Cardiovascular Diseases / drug therapy
  • Cardiovascular Diseases / enzymology
  • Cardiovascular Diseases / genetics
  • Cardiovascular Diseases / metabolism*
  • Cholesterol / metabolism
  • Endothelium, Vascular / enzymology
  • Endothelium, Vascular / metabolism
  • Enzyme Activation
  • Gene Expression Regulation
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Nitric Oxide Synthase / metabolism
  • Nitric Oxide Synthase Type III
  • rho GTP-Binding Proteins / antagonists & inhibitors
  • rho GTP-Binding Proteins / genetics
  • rho GTP-Binding Proteins / metabolism*

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Cholesterol
  • NOS3 protein, human
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type III
  • rho GTP-Binding Proteins